Literature DB >> 3489469

Macrophage activation in rat models of inflammation and arthritis. Systemic activation precedes arthritis induction and progression.

W J Johnson, K A Muirhead, P C Meunier, B J Votta, T C Schmitt, M J DiMartino, N Hanna.   

Abstract

The association between the induction and progression of adjuvant-induced arthritis (AA) and the development of synovial and systemic macrophage activation was assessed by studying the temporal development of these parameters in a rat model. Rats with AA developed significant edema of the uninjected hind leg beginning 10 days post-adjuvant injection, with progressive increases in edema continuing through day 17. Several parameters of macrophage activation, including the enhanced ability to secrete interleukin-1 and prostaglandin E2, kill tumor cells, accumulate fluorescent cyanine dyes, emigrate into the peritoneal cavity and synovium, and express Ia antigen, as well as the decreased ability to secrete superoxide anion, were associated temporally with the development of the arthritic lesion. In addition to the temporal association between macrophage activation and development of arthritis, a positive correlation between macrophage activation and arthritis induction was seen with the use of synthetic adjuvants at arthritogenic and nonarthritogenic doses. These data taken together suggest that induction and progression of AA in rats is associated with both systemic (blood, spleen, and peritoneal cavity) and local (synovium) macrophage activation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489469     DOI: 10.1002/art.1780290910

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  15 in total

1.  Differential effects of anti-arthritic agents on subnormal plasma iron levels in adjuvant arthritic rats.

Authors:  K M Connolly; V J Stecher; P T Speight; R Becker; J Rathman
Journal:  Agents Actions       Date:  1989-06

2.  Eicosanoid production and phospholipase A2 secretion by peritoneal macrophages from rats with adjuvant-induced arthritis.

Authors:  C E Bak; C M Anderson; A C Hanglow; D W Morgan
Journal:  Agents Actions       Date:  1991-09

3.  Pharmacological investigation of acute cellular accumulation in immunological air pouch inflammation.

Authors:  P Hambleton; P Miller
Journal:  Agents Actions       Date:  1989-08

4.  Activation of macrophages in an experimental rat model of arthritis induced by Erysipelothrix rhusiopathiae infection.

Authors:  H Renz; U Gentz; A Schmidt; T Dapper; M Nain; D Gemsa
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

5.  An experimental study of the neurogenic and the immunological contribution to "tennis elbow" in rats.

Authors:  E Haker; E Theodorsson; T Lundeberg
Journal:  Inflammation       Date:  1997-02       Impact factor: 4.092

6.  Anti-inflammatory properties and inhibition of leukotriene C4 biosynthesis in vitro by flavonoid baicalein from Scutellaria baicalensis georgy roots.

Authors:  I G Butenko; S V Gladtchenko; S V Galushko
Journal:  Agents Actions       Date:  1993

7.  Adjuvant arthritic (AA) rats exhibit enhanced endotoxin-induced plasma TNF (EIPT) levels.

Authors:  M DiMartino; M Slivjak; K Esser; C Wolff; E Smith; R Gagnon
Journal:  Agents Actions       Date:  1993

8.  Drug actions on delayed-type hypersensitivity in rats with developing and established adjuvant arthritis.

Authors:  P Hambleton; S McMahon
Journal:  Agents Actions       Date:  1990-03

9.  Effect of acetylsalicylic acid and dexamethasone on antibody production in adjuvant arthritis.

Authors:  A Franch; C Castellote; M Castell
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

10.  Imaging of carrageenan-induced local inflammation and adjuvant-induced systemic arthritis with [(11)C]PBR28 PET.

Authors:  Xia Shao; Xueding Wang; Sean J English; Timothy Desmond; Phillip S Sherman; Carole A Quesada; Morand R Piert
Journal:  Nucl Med Biol       Date:  2013-07-25       Impact factor: 2.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.